Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

CI Global Health Sciences Corporate Class

+ Add to Watchlist

UNISHSCI:CN

59.55 CAD 0.14 0.23%

As of 07:59:30 ET on 05/29/2015.

Snapshot for CI Global Health Sciences Corporate Class (UNISHSCI)

Year To Date: +17.50% 3-Month: +2.71% 3-Year: +38.78% 52-Week Range: 44.93 - 62.10
1-Month: +4.20% 1-Year: +30.19% 5-Year: +27.42% Beta vs CXBT: 0.73

Mutual Fund Chart for UNISHSCI

No chart data available.
  • UNISHSCI:CN 59.55
  • 1M
  • 1Y
Interactive UNISHSCI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UNISHSCI

CI Global Health Sciences Corporate Class is an open-end fund incorporated in Canada. The Fund seeks to obtain maximum long-term capital growth. The Fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.

Inception Date: 07-23-1996 Telephone: 1-800-268-9374
Managers: ANDREW WAIGHT
Web Site: www.ci.com

Fundamentals for UNISHSCI

NAV (on 2015-05-29) 59.55
Assets (M) (on 2015-03-31) 369.85
Fund Leveraged N
Minimum Investment 500.00
Minimum Subsequent Investment 50.00

Dividends for UNISHSCI

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2015-03-27) 0.48
Dividend Yield (ttm) 5.05

Fees & Expenses for UNISHSCI

Front Load 5.00
Back Load 5.50
Current Mgmt Fee 2.00
Redemption Fee 2.00
12b1 Fee -
Expense Ratio 2.22

Top Fund Holdings for UNISHSCI

Filing Date: 04/30/2015
Name Position Value % of Total
Intercept Pharmaceuticals Inc 73,800 22,510,229 5.678%
Sanofi 155,000 19,152,136 4.831%
Boston Scientific Corp 829,700 17,838,490 4.500%
Roche Holding AG 48,400 16,864,940 4.254%
Air Methods Corp 294,000 16,210,366 4.089%
NxStage Medical Inc 666,300 14,735,388 3.717%
BioMarin Pharmaceutical Inc 107,168 14,487,928 3.655%
NuVasive Inc 247,750 13,370,322 3.373%
Novartis AG 105,000 13,126,019 3.311%
Synergy Health PLC 255,361 10,478,023 2.643%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil